Sana Biotechnology, Inc. (SANA) saw its stock price plummet by 5.24% during intraday trading on Thursday, as investors reacted to negative news regarding the company's risk exposure.
The decline followed the disclosure of a new risk category related to AI adoption, which exposes Sana Biotechnology to rising data, compliance, and reputational risks. This announcement raised concerns among investors about potential material impacts on the company's operations and future performance.